FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3007620394> ?p ?o ?g. }

• W3007620394 endingPage "S65" @default.
• W3007620394 startingPage "S64" @default.
• W3007620394 abstract "Surgical Resection is considered curative for those with solitary hepatocellular carcinoma (HCC) and preserved liver function, but it is limited to those with adequate future liver remnant (FLR). Radioembolization (Y90) is used to improve margins and increase FLR, converting patients to surgical candidates. We aimed to study outcome differences between HCC patients who underwent resection vs. those requiring neoadjuvant Y90 prior to resection. With IRB approval, we studied patients with HCC resected between 2011-2014. Patients were categorized as resectable per multidiscipline tumor board vs. those deemed initially unresectable but converted to surgical resection with neoadjuvant Y90 (radiation lobectomy). Recurrence and survival outcomes were compared between these cohorts. Time to recurrence (TTR), recurrence free survival (RFS), and overall survival (OS) and were estimated using Kaplan-Meier method. 17 treatment naïve patients underwent surgical resection vs. 13 HCC patients that required neoadjuvant Y90. Mean age was 60 for resection cohort vs. 63 for neoadjuvant Y90 cohort (P = 0.5). Median tumor size was 4.1 cm in resection cohort vs. 5.6 cm for neoadjuvant Y90 cohort (P = 0.28). All patients had Child-Pugh A liver function. There was 1 (6%) 90-day mortality rate in resection cohort and 0% in neoadjuvant Y90 cohort. Resection cohort explants showed 100% viable tumors without necrosis. At explant, 5 (38%) had complete tumor necrosis and 8 (62%) had partial (>50%) necrosis in the neoadjuvant Y90 cohort. Time to recurrence analysis was similar between cohorts; median was not reached at 80 months follow-up. RFS was similar between cohorts, where 5-year RFS was 51% for resection cohort vs. 56% for neoadjuvant Y90 cohort (P = 0.67). Overall survival outcomes were also similar between cohorts, with 5-year OS of 74% for resection patients vs. 83% for neoadjuvant Y90 patients (P = 0.59). Neoadjuvant Y90 can convert patients with HCC initially declared unresectable and denied surgery into resection candidates. This approach imparts the same recurrence and survival advantages as those deemed optimal resection candidates at presentation." @default.
• W3007620394 created "2020-03-06" @default.
• W3007620394 creator A5011003738 @default.
• W3007620394 creator A5033464248 @default.
• W3007620394 creator A5034975837 @default.
• W3007620394 creator A5044862107 @default.
• W3007620394 creator A5053309294 @default.
• W3007620394 creator A5075153200 @default.
• W3007620394 creator A5087536545 @default.
• W3007620394 date "2020-03-01" @default.
• W3007620394 modified "2023-09-26" @default.
• W3007620394 title "3:09 PM Abstract No. 138 Comparative outcome study of surgically resectable hepatocellular carcinoma patients versus those requiring neoadjuvant radioembolization prior to surgical resection" @default.
• W3007620394 doi "https://doi.org/10.1016/j.jvir.2019.12.171" @default.
• W3007620394 hasPublicationYear "2020" @default.
• W3007620394 type Work @default.
• W3007620394 sameAs 3007620394 @default.
• W3007620394 citedByCount "0" @default.
• W3007620394 crossrefType "journal-article" @default.
• W3007620394 hasAuthorship W3007620394A5011003738 @default.
• W3007620394 hasAuthorship W3007620394A5033464248 @default.
• W3007620394 hasAuthorship W3007620394A5034975837 @default.
• W3007620394 hasAuthorship W3007620394A5044862107 @default.
• W3007620394 hasAuthorship W3007620394A5053309294 @default.
• W3007620394 hasAuthorship W3007620394A5075153200 @default.
• W3007620394 hasAuthorship W3007620394A5087536545 @default.
• W3007620394 hasBestOaLocation W30076203941 @default.
• W3007620394 hasConcept C121608353 @default.
• W3007620394 hasConcept C126322002 @default.
• W3007620394 hasConcept C141071460 @default.
• W3007620394 hasConcept C143998085 @default.
• W3007620394 hasConcept C2778019345 @default.
• W3007620394 hasConcept C2778292576 @default.
• W3007620394 hasConcept C503630168 @default.
• W3007620394 hasConcept C530470458 @default.
• W3007620394 hasConcept C71924100 @default.
• W3007620394 hasConcept C72563966 @default.
• W3007620394 hasConceptScore W3007620394C121608353 @default.
• W3007620394 hasConceptScore W3007620394C126322002 @default.
• W3007620394 hasConceptScore W3007620394C141071460 @default.
• W3007620394 hasConceptScore W3007620394C143998085 @default.
• W3007620394 hasConceptScore W3007620394C2778019345 @default.
• W3007620394 hasConceptScore W3007620394C2778292576 @default.
• W3007620394 hasConceptScore W3007620394C503630168 @default.
• W3007620394 hasConceptScore W3007620394C530470458 @default.
• W3007620394 hasConceptScore W3007620394C71924100 @default.
• W3007620394 hasConceptScore W3007620394C72563966 @default.
• W3007620394 hasIssue "3" @default.
• W3007620394 hasLocation W30076203941 @default.
• W3007620394 hasOpenAccess W3007620394 @default.
• W3007620394 hasPrimaryLocation W30076203941 @default.
• W3007620394 hasRelatedWork W2002120878 @default.
• W3007620394 hasRelatedWork W2003938723 @default.
• W3007620394 hasRelatedWork W2047967234 @default.
• W3007620394 hasRelatedWork W2118496982 @default.
• W3007620394 hasRelatedWork W2439875401 @default.
• W3007620394 hasRelatedWork W2603773853 @default.
• W3007620394 hasRelatedWork W2980939722 @default.
• W3007620394 hasRelatedWork W4238867864 @default.
• W3007620394 hasRelatedWork W4240236077 @default.
• W3007620394 hasRelatedWork W2525756941 @default.
• W3007620394 hasVolume "31" @default.
• W3007620394 isParatext "false" @default.
• W3007620394 isRetracted "false" @default.
• W3007620394 magId "3007620394" @default.
• W3007620394 workType "article" @default.